hydroxychloroquine has been researched along with povidone-iodine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Effenberger, M; Eisenhut, M; Kronbichler, A; Lee, KH; Shin, JI | 1 |
| Cook, AR; Fisher, D; Goh, BC; Hartman, M; Koo, CY; Lakshminarasappa, SR; Loh, KS; Ooi, DSQ; Quek, AML; Seet, RCS; Sengupta, S; So, JBY; Sun, J; Tambyah, PA; Teoh, HL | 1 |
1 review(s) available for hydroxychloroquine and povidone-iodine
| Article | Year |
|---|---|
Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view.
Topics: Anti-Bacterial Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Humans; Hydroxychloroquine; Lung; Morbidity; Mouthwashes; Nasal Sprays; Pandemics; Plant Preparations; Pneumonia, Viral; Povidone-Iodine; Sambucus; SARS-CoV-2; Smoking Cessation; Steroids | 2020 |
1 trial(s) available for hydroxychloroquine and povidone-iodine
| Article | Year |
|---|---|
Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial.
Topics: Adult; COVID-19; Humans; Hydroxychloroquine; Male; Middle Aged; Pharynx; Povidone-Iodine; Time Factors; Treatment Outcome; Young Adult | 2021 |